Company Profile
PharmaResearch is a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes. Its portfolio also includes JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid, ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients, PLACENTEX injection for the treatment and tissue restoration of wounds, CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration, Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles, and Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc. ; and Rejuvenex cream, which treats the wound through rapid tissue regeneration, as well as REJURAN, a medical device for face (especially eye, perioral area), neck, Décolleté, hands, etc. Its portfolio also includes CLEVIEL prime plus and contour plus with lidocaine medical devices, D+CELL 350 TRA I, REJURAN moisturizer for daily skin protection, as well as REJUVENEX SCULPT V, REJURAN concentrate for sensitive and aged skin, REJURAN healing eye gel and mask, REJURAN sunscreen that protects skin from UV rays, and REJURAN recover soothing mask.
Additionally, it offers D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products.
Its portfolio also includes REJURAN tone-up booster, REJURAN FORTE, and CONJURAN medical devices, as well as functional foods Engages in the development of software and consulting businesses. Founded in 1993 and headquartered in Gangneung-si, South Korea, PharmaResearch was formerly known as Pharma Research Products Co., Ltd. before rebranding in April 2021.